

Her concerns about preventing and responding to antisemitism on college campuses motivated her to volunteer for the Board of Directors of Temple Hillel, where she is now serving as Secretary of the Board. She is passionate about the heritage of the Jewish people and about their right to exist in the United States and in Israel. She began her career as an Instructor at Temple Medical School and rose through the ranks to her present position. She is a native Philadelphian and graduated from the Philadelphia High School for Girls. She is Director of the Cell and Immunology Core Laboratory that is part of a designated national Center of Excellence funded by the National Institute on Drug Abuse at NIH. Her laboratory in CSAR investigates the effects of abused substances, particularly opioids and cannabinoids, on immune responses. She is Co-Director of the Center for Substance Abuse Research (CSAR). She is a basic scientist with appointments in the Department of Microbiology, Immunology and Inflammation, and the Department of Neural Sciences. Eisenstein is a Professor at the Lewis Katz School of Medicine of Temple University.

He, too, is the Co-chair of the Jewish Federation of Greater Philadelphia’s Community Engagement Committee and Leadership Cabinet, and a member of their Board of Trustees, Co-chair of the Board of Temple University Hillel, a member of Congregation Rodeph Shalom’s Board of Directors, Co-chair of their membership taskforce, and a past president and trustee of Jewish Learning Venture.ĭr. There, Broder served as Vice President of Corporate Development and Chief Legal Officer where he managed Conrail’s legal and corporate affairs, as well as its real estate and business development departments.īroder is an Adjunct Professor at Temple University’s School of Law and Coeditor of The Temple 10Q: Temple’s Business Law Magazine.


After receiving his JD and working in private practice as a litigator for several years, he joined Conrail’s law department in 1988, where he specialized in economic regulatory litigation, antitrust compliance, and general commercial litigation. He also received an MA (2011) and MPhil (2019) from the University Pennsylvania. Broder received a BA from Oberlin College and a JD from Temple in 1983.
